Cassidy L. Klima

Cassidy L. Klima

Auto-generated profile, based on publicly available information

Cassidy L. Klima

Lethbridge Research and Development Centre, Agriculture and Agri-Food Canada, Lethbridge, Alberta, Canada

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
CKCassidy L. Klima
Cassidy L. Klima
RZRahat Zaheer
Rahat Zaheer
SCShaun R. Cook
Shaun R. Cook
CBCalvin W. Booker
Calvin W. Booker
SHSteve Hendrick
Steve Hendrick
Tim McAllisterTim McAllister
Tim McAllister
In this study, we determined the prevalence of bovine respiratory disease (BRD)-associated viral and bacterial pathogens in cattle and characterized the genetic profiles, antimicrobial susceptibilities, and nature of antimicrobial resistance determinants in collected bacteria. Nasopharyngeal swab and lung tissue samples from 68 BRD mortalities in Alberta, Canada (n= 42), Texas (n= 6), and Nebraska (n= 20) were screened using PCR for bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus, bovine herpesvirus 1, parainfluenza type 3 virus,Mycoplasma bovis,Mannheimia haemolytica,Pasteurella multocida, andHistophilus somni. Excepting bovine herpesvirus 1, all agents were detected.M. haemolytica(91%) and BVDV (69%) were the most prevalent, with cooccurrence in 63% of the cattle. Isolates ofM. haemolytica(n= 55),P. multocida(n= 8), andH. somni(n= 10) from lungs were also collected. AmongM. haemolyticaisolates, a clonal subpopulation (n= 8) was obtained from a Nebraskan feedlot. All three bacterial pathogens exhibited a high rate of antimicrobial resistance, with 45% exhibiting resistance to three or more antimicrobials.M. haemolytica(n= 18),P. multocida(n= 3), andH. somni(n= 3) from Texas and Nebraska possessed integrative conjugative elements (ICE) that conferred resistance for up to seven different antimicrobial classes. ICE were shown to be transferred via conjugation fromP. multocidatoEscherichia coliand fromM. haemolyticaandH. somnitoP. multocida. ICE-mediated multidrug-resistant profiles of bacterial BRD pathogens could be a major detriment to many of the therapeutic antimicrobial strategies currently used to control BRD.

20 September 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
JMJoel J Maki
Joel J Maki
CKCassidy L. Klima
Cassidy L. Klima
MSMatthew J. Sylte
Matthew J. Sylte
TLTorey Looft
Torey Looft
The loss of antibiotics as a tool to improve feed efficiency in poultry production has increased the urgency to understand how the microbiota interacts with animals to impact productivity and health. Modulating and harnessing microbiota-host interactions is a promising way to promote poultry health and production efficiencies without antibiotics. In poultry, the microbiome is influenced by many host and external factors including host species, age, gut compartment, diet, and environmental exposure to microbes. Because so many factors contribute to the microbiota composition, specific knowledge is needed to predict how the microbiome will respond to interventions. The effects of antibiotics on microbiomes have been well documented, with different classes of antibiotics having distinctive, specific outcomes on bacterial functions and membership. Non-antibiotic interventions, such as probiotics and prebiotics, target specific bacterial taxa or function to enhance beneficial properties of microbes in the gut. Beneficial bacteria provide a benefit by displacing pathogens and/or producing metabolites (e.g., short chain fatty acids or tryptophan metabolites) that promote poultry health by improving mucosal barrier function or immune function. Microbiota modulation has been used as a tool to reduce pathogen carriage, improve growth, and modulate the immune system. An increased understanding of how the microbiota interacts with animal hosts will improve microbiome intervention strategies to mitigate production losses without the need for antibiotics.

1 May 2011 in Veterinary Microbiology
Verified
Journal Article
Closed access
CKC.L. Klima
C.L. Klima
TAT.W. Alexander
T.W. Alexander
RRR.R. Read
R.R. Read
SGS.P. Gow
S.P. Gow
CBC.W. Booker
C.W. Booker
LSL.B. Selinger
L.B. Selinger

1 January 2013 in Frontiers in Microbiology
Verified
Journal Article
Open access
RZRahat Zaheer
Rahat Zaheer
SCShaun R. Cook
Shaun R. Cook
CKCassidy L. Klima
Cassidy L. Klima
KSKim Stanford
Kim Stanford
TATrevor Alexander
Trevor Alexander
Tim McAllisterTim McAllister
Tim McAllister
Macrolides are the first-line treatment against bovine respiratory disease, and are also used to treat infections in humans. The macrolide, tylosin phosphate, is often included in the diet of cattle as a preventative for liver abscesses in many regions of the world outside of Europe. This study investigated the effects of administering macrolides to beef cattle either systemically through a single subcutaneous injection (therapeutic) or continuously in-feed (subtherapeutic), on the prevalence and antimicrobial resistance of Mannheimia haemolytica and Enterococcus spp. isolated from the nasopharynx and faeces, respectively. Nasopharyngeal and faecal samples were collected weekly over 28 days from untreated beef steers and from steers injected once with tilmicosin or tulathromycin or continuously fed tylosin phosphate at dosages recommended by manufacturers. Tilmicosin and tulathromycin were effective in lowering (P < 0.05) the prevalence of M. haemolytica, whereas subtherpeutic tylosin had no effect. M. haemolytica isolated from control- and macrolide-treated animals were susceptible to macrolides as well as to other antibiotics. Major bacteria co-isolated with M. haemolytica included Pasteurella multocida, Staphylococcus spp., Acinetobacter spp., E. coli and Bacillus spp. With the exception of M. haemolytica and P. multocida, erythromycin resistance was frequently found in other isolated species. Both methods of macrolide administration increased (P < 0.05) the levels erythromycin-resistance enterococci in faeces. Development of resistance to injectable macrolides in bacteria isolated from the nasopharynx was species dependent. Therapeutic administration of tilmicosin and tularthromycin selected for macrolide resistant bacteria within both the respiratory and intestinal tract, whereas suptherapeutic administration of tylosin only selected for macrolide resistance in enteric bacteria.

4 December 2017 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
RAR. Michele Anholt
R. Michele Anholt
CKCassidy Klima
Cassidy Klima
NANick Allan
Nick Allan
HMHeather Matheson-Bird
Heather Matheson-Bird
CSCrystal Schatz
Crystal Schatz
BRBrenda Ralston
Brenda Ralston
Bovine respiratory disease (BRD) is the most important illness of feedlot cattle. Disease management targets the associated bacterial pathogens, Mannheimia haemolytica, Mycoplasma bovis, Pasteurella multocida, Histophilus somni, and Trueperella pyogenes. We conducted a cross-sectional study to measure the frequencies of antimicrobial-resistant BRD pathogens using a collaborative network of veterinarians, industry, government, and a diagnostic laboratory. Seven private veterinary practices in southern Alberta collected samples from both living and dead BRD-affected animals at commercial feedlots. Susceptibility testing of 745 isolates showed that 100% of the M. haemolytica, M. bovis, P. multocida, and T. pyogenes isolates and 66.7% of the H. somni isolates were resistant to at least one antimicrobial class. Resistance to macrolide antimicrobials (90.2% of all isolates) was notable for their importance to beef production and human medicine. Multidrug resistance (MDR) was high in all target pathogens with 47.2% of the isolates resistant to four or five antimicrobial classes and 24.0% resistance to six to nine classes. We compared the MDR profiles of isolates from two feedlots serviced by different veterinary practices. Differences in the average number of resistant classes were found for M. haemolytica (p < 0.001) and P. multocida (p = 0.002). Compared to previous studies, this study suggests an increasing trend of resistance in BRD pathogens against the antimicrobials used to manage the disease in Alberta. For the veterinary clinician, the results emphasize the importance of ongoing susceptibility testing of BRD pathogens to inform treatment protocols. Surveillance studies that collect additional epidemiological information and manage sampling bias will be necessary to develop strategies to limit the spread of resistance.

27 March 2019 in Microbial Ecology
Verified
Journal Article
Closed access
PDF file
CKCassidy L. Klima
Cassidy L. Klima
DHDevin B. Holman
Devin B. Holman
BRBrenda J. Ralston
Brenda J. Ralston
KSKim Stanford
Kim Stanford
RZRahat Zaheer
Rahat Zaheer
Tim McAllisterTim McAllister
Tim McAllister